Arrow Mark Colorado Holdings LLC Talis Biomedical Corp Transaction History

Arrow Mark Colorado Holdings LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.48 - $0.64 $326,473 - $435,298	-680,154 Reduced 58.68%	478,862 $234,000
Q4 2022 Feb 14, 2023	SELL	$0.45 - $11.67 $16,851 - $437,006	-37,447 Reduced 3.13%	1,159,016 $521,000
Q3 2022 Nov 14, 2022	SELL	$0.7 - $10.79 $1.14 Million - $17.5 Million	-1,623,610 Reduced 57.57%	1,196,463 $816,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.44 $741,282 - $1.32 Million	-915,164 Reduced 24.5%	2,820,073 $2.29 Million
Q1 2022 May 16, 2022	SELL	$1.3 - $4.19 $1.53 Million - $4.94 Million	-1,180,002 Reduced 24.01%	3,735,237 $5.27 Million
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.17 $3.73 Million - $6.04 Million	-978,637 Reduced 16.6%	4,915,239 $19.7 Million
Q3 2021 Nov 15, 2021	BUY	$6.02 - $12.46 $132,145 - $273,509	21,951 Added 0.37%	5,893,876 $36.8 Million
Q2 2021 Aug 16, 2021	SELL	$9.62 - $14.56 $1.25 Million - $1.89 Million	-130,046 Reduced 2.17%	5,871,925 $32.7 Million
Q1 2021 May 17, 2021	BUY	$11.2 - $27.8 $67.2 Million - $167 Million	6,001,971 New	6,001,971 $77.1 Million

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.